Patents expiring in 2035

US 8980907

Dendrimer conjugates

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980883

Arylpiperazine derivatives and methods of utilizing same

REVIVA PHARMACEUTICALS, INC. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980871

Methods of treatment for hemolysis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980268

Methods for treating cancer by administering an anti-Ang-2 antibody

REGENERON PHARMACEUTICALS, INC. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980887

2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, preparation methods and uses thereof

Toxicology Academy of Military Medical Sciences P.L.A., China · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980899

Methods of inhibiting Ire1

The Regents of the University of California · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980608

High molecular weight heparosan polymers and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980549

MicroRNA patterns for the diagnosis, prognosis and treatment of melanoma

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980822

Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980836

Method of treating degenerative disorders of the nervous system

The Regents of the University of California · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980304

Barrel-shaped vaginal ring

TEVA WOMEN'S HEALTH, INC. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8979831

Thermochemical ablation system using heat from delivery of electrophiles

Regents of the University of Minnesota · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980266

Serpin fusion polypeptides and methods of use thereof

Inhibrx, Inc. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980343

Plant extract, compositions containing same, method of extraction and uses thereof

Botanic Century (Beijing) Co. Ltd. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980859

Aegyptin and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980921

AMPK-activating heterocyclic compounds and methods for using the same

Rigel Pharmaceuticals, Inc. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980302

Therapeutic implant

Covidien LP · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2846808

ZUCKERZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON HÄMOPHILIE A UND/ODER VON-WILLEBRAND-SYNDROM

CSL BEHRING GMBH [DE] · Granted Wed Mar 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Mar 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2847225

ANTIKÖRPER GEGEN CLAUDIN 18.2 FÜR DIE KREBSDIAGNOSE

GANYMED PHARMACEUTICALS AG [DE] · Granted Wed Mar 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Mar 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2015036507

UTILISATION DE CABAZITAXEL CHEZ DES PATIENTS CHEZ QUI UN CANCER DU POUMON NON À PETITES CELLULES MÉTASTATIQUE CONTINUE À PROGRESSER APRÈS UN TRAITEMENT À BASE DE DOCÉTAXEL

AVENTIS PHARMA SA [FR] · Granted Thu Mar 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8986653

Labeled iodinated tropane formulation

Alseres Pharmaceuticals, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987308

Compounds for the treatment of Clostridium difficile-associated disease

Summit Corporation Plc · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987309

Compounds, pharmaceutical compositions and methods of use of 2-aryl pyridylazoles

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8989847

Method of measuring propulsion in lymphatic structures

The Board of Regents of the University of Texas System · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8986736

Method for delivering particulate drugs to tissues

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987426

Immunotoxin fusion proteins and means for expression thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987332

Methods of treating inflammatory conditions

The Regents of the University of California · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8986695

Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987296

Acridone compounds

The United States of America DBA The Department of Veterans Affairs · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987289

Methods for treating pruritus

Trevi Therapeutics, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987294

Small molecule inhibitors of the α4-paxillin interaction

The Regents of the University of California · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987377

Poly(amide) polymers for the delivery of oligonucleotides

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987227

Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987228

Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-idobenzyl)-adenin-9-yl]-N-methyl-β-D-ribofuronamide(IB-MECA/CF-101) for treatment of psoriasis

CAN-FITE BIOPHARMA LTD. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987198

Compositions and methods for treating obesity and diabetes

United States Department of Agriculture · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987192

Potent and selective mediators of cholesterol efflux

The Regents of the University of California · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987189

Treating hepatitis C virus infection

The Board of Regents of the University of Texas System · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987216

Polysulfated glycosides and salts thereof

Teva Hungary Pharmaceutical Marketing Private Limited Company · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8986935

Methods for treating spinal muscular atrophy

PTC THERAPEUTICS, INC. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8986757

Essential oils inhibit mold on wood

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8986701

Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8986708

Combinations of gene deletions for live attenuated Shigella vaccine strains

The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8986688

WAP domain fusion polypeptides and methods of use thereof

Inhibrx, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8986737

Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth

The Board of Regents of the University of Texas System · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8986005

Strip for transferring a therapeutic composition to a tooth

DISCUS DENTAL, LLC · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987237

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987303

AMPK-activating heterocyclic compounds and methods for using the same

Rigel Pharmaceuticals, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8987238

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)